Jeremy Flynn

Contact Information

HA169 Chandler Medical Center
800 Rose Street
Lexington, KY 40536

phone: 859-323-0076
fax: 859-323-2049

Contact by email

Positions

  • Cardiothoracic Surgery/Heart & Lung Transplant Clinical Pharmacy Specialist
    UK Chandler Medical Center
  • Adjunct Assistant Professor
    Pharmacy Practice and Science Department

Licensure

  • Pharmacist
    Commonwealth of Kentucky, 1999

Specialty Certification

  • 2005 Pharmacotherapy BCPS

Scholarly/Research Interests

  • Minimization of bleeding in cardiac surgery
  • Effect of guideline compliance on patient outcomes
  • Antifibrinolytic and Antiplatelet therapy in cardiac surgery

 

Jeremy Flynn - Pharm.D.

Dr. Flynn received his doctor of pharmacy degree from the University of Kentucky in 1999 and subsequently completed a pharmacy practice and critical care specialty residency at the University of Kentucky Chandler Medical Center. He then spent two years in Dr. Scott Akers lab as a fellow in Cardiovascular Translational Research.

Dr. Flynn's current responsibilities include providing comprehensive pharmaceutical care to critically ill patients at the UK Chandler Medical Center and facilitating the care of all patients on the cardiothoracic surgery service as well as the heart and lung transplant patients. Teaching activities include precepting both students and residents on the cardiothoracic surgery service, participating in the therapeutics curriculum, and co-coordinating the critical care elective. He currently serves as the assistant director of the cardiovascular translational research fellowship. His current research interests are focused on optimizing drug therapy in the cardiothoracic surgery and heart/lung transplant populations.

Selected Honors

  • Preceptor of the Year Award - University of Kentucky Pharmacy Residency (2004)
  • Best Student, Resident, Fellow Paper Award - American College of Clinical Pharmacy Annual Meeting (2003)

Selected Publications/Presentations

  • Cook AM, Flynn JD, Romanelli F. An Evaluation of a New Critical Care Elective Course. Journal of Pharmacy Teaching 2006;13(1):37-47.
  • Oh JJ, Akers WS, Lewis D, Ramaiah C, Flynn JD. Recombinant Factor VIIa for Refractory Bleeding Following Cardiac Surgery using a Direct Thrombin Inhibitor to Facilitate Cardiopulmonary Bypass in a patient with Heparin-Induced Thrombocytopenia. Pharmacotherapy 2006;26(4):576-577.
  • Blancett JR, Flynn JD, Akers WS, Smith KM. Staying in Rhythm Part 2: Management of Patients at Risk for Torsade de Pointes. Orthopedics 2006;29:31-33.
  • Blancett JR, Smith KM, Akers WS, Flynn JD. Staying in Rhythm Part 1: Identifying Risk Factors for Torsade de Pointes. Orthopedics 2005;28:1417-20.
  • LeClaire AC, Mullet TW, Jahania SA, Flynn JD. Methemoglobinemia secondary to topical benzocaine use in a lung transplant patient. Ann Pharmacother 2005;39:373-6.
  • Weant KA, Flynn JD, Smith K. Postoperative Hypertension. Orthopedics 2004; 27(11): 1-3.
  • Flynn JD, Pajoumand M, Camp PC, Jahania SA, Ramaiah C, Akers WS. Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation. Ann Pharmacother 2004;38:1639-1642.
  • Flynn JD, Camp PC, Jahania SA, Ramaiah C, Akers WS. Successful Treatment of Life Threatening Bleeding following Bridging from Acute-to-Chronic Left Ventricular Assist Device Support with Recombinant Activated Factor VII (rFVIIa). ASAIO 2004;50(5): 519-21.
  • Flynn JD, Akers WS, Jones M, Stevkovic N, Waid T, Mullett T, Jahania SA. Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: Case report and review of the literature. Pharmacotherapy 2004;24(7):932-938.
  • Flynn JD, Camp PC, Jahania SA, Ramaiah C, Akers WS. Successful Treatment of Life Threatening Bleeding following Bridging from Acute-to-Chronic Left Ventricular Assist Device Support with Recombinant Activated Factor VII (rFVIIa). ASAIO 2004;50(5): 519-21.
  • Flynn JD, Pajoumand M, Camp PC, Jahania SA, Ramaiah C, Akers WS. Recombinant Factor VIIa for Refractory Bleeding Following Orthotopic Heart Transplantation. Ann Pharmacother 2004;38:1639-1642.
  • Flynn JD, Post G, Akers WS. The Effects of the Angiotensin II Subtype Receptor Antagonist, Losartan, on the Functional Recovery of Isolated Rat Hearts Undergoing Global Myocardial Ischemia-Reperfusion. Pharmacotherapy 2003;23(11): 1401-1410.
  • Akers WS, Flynn JD, Davis G, Green A, Winstead PS, Stroebel G. Prolonged cardiac repolarization following tacrolimus and haloperidol administration in the critically ill patient. Pharmacotherapy 2004;24(3):404-408.
  • Akers WS, Shah S, Flynn JD, Apparsundaram S. The effect of clonidine on cardiac norepinephrine spillover in the isolated rat heart. J Cardiovasc Pharmacol 2004;43:830-838.
page last modified: October 25 2012     

© University of Kentucky College of Pharmacy
Official Site of the University of Kentucky College of Pharmacy